Foundation for Innovative New Diagnostics (FIND)
Geneva, Genève, Switzerland
Purpose
to get to the “ground truth” of Mycobacterial Lipoarabinomannan (LAM) presence, concentration and temporality as a urine biomarker for TB, informing critical decisions for development of TB point-of-care diagnostics
Division
Global Health
Date
November 2019
Region Served
GLOBAL
Committed amount
$456,800
Grant topic
Tuberculosis
Duration (months)
29
Grantee location
Geneva, Genève, Switzerland
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.